Ocular Therapeutix

IPO

Transforming Retinal Disease Treatment with AXPAXLI™

Public · Bedford, United States · Founded 2006 · $836.7M raised

Employees
201–500
Founded
2006
Business Model
B2B
Website
ocutx.com
Total Funding
$836.7M
Last Round
$475.0M Private EquitySep 2025
Rounds
8
Type
Public

About

Ocular Therapeutix is a biopharmaceutical company focused on developing and commercializing innovative therapies for diseases of the eye, utilizing its proprietary ELUTYX hydrogel platform to deliver sustained-release drug delivery directly to ocular tissues.

Summary

Ocular Therapeutix is a Biotech company based in Bedford, United States, founded in 2006. It has raised $836.7M in total across 8 rounds, most recently a $475.0M Private Equity round in Sep 2025. Investors include Ascension Health and Polaris Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Private EquityPrivate EquitySep 2025
$475.0M

Sign up to see all 9 rounds

Seed through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ocular Therapeutix on Indexed.vc
<a href="https://indexed.vc/companies/ocular-therapeutix"><img src="https://indexed.vc/api/badge/company/ocular-therapeutix" alt="Ocular Therapeutix on Indexed.vc" width="260" height="76" /></a>